23.03.2005 13:53:00

Syneron to Present at Smith Barney and Lehman Brothers Healthcare Conf

Syneron to Present at Smith Barney and Lehman Brothers Healthcare Conferences


    Business Editors/Health/Medical Writers

    YOKNEAM, Israel--(BUSINESS WIRE)--March 23, 2005--Syneron Medical Ltd. (Nasdaq:ELOS), an innovator in the development, marketing and sales of ELOS(TM) combined-energy medical aesthetic devices, today announced that it will be presenting at both the Smith Barney Group 2005 Healthcare Conference in Washington, D.C. on March 31, 2005 and at the Lehman Brothers Eighth Annual Global Healthcare Conference in Miami, Florida on April 1, 2005.
    Dr. Shimon Eckhouse, Chairman of the Board of Syneron, will be speaking to investors at the Smith Barney conference in Washington at 8:00 am EST on March 31. Dr. Eckhouse will also present to investors at the Lehman Brothers conference at 10:15 am EST on April 1.
    Both presentations will be webcast live from the two conferences and replays of the webcasts will be archived on the Syneron website. To access the live webcasts or replays, please click on the Investor Relations link on the Syneron Medical website at www.syneron.com and follow the instructions.

    About Syneron

    Syneron Medical Ltd. (Nasdaq:ELOS) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented ELOS combined-energy technology of Bi-Polar Radio Frequency and Light. The Company's innovative ELOS technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American Headquarters in Canada, European Headquarters in Germany, and Asia-Pacific Headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at www.syneron.com.

Syneron Medical Ltd. Soltam Technology Park POB 550 Yokneam Illit, 20692 Israel Tel: +972 4 909-6200 Fax: +972 4 909-6202 info@syneron-med.com

    Syneron, the Syneron logo and ELOS are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. ELOS (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.

--30--KK/se*

CONTACT: Syneron Medical Ltd. Moshe Mizrahy, CEO, +972-4-909-6349 moshem@syneron-med.com David Schlachet, CFO, +972-4-909-6376 davids@syneron-med.com

KEYWORD: FLORIDA DISTRICT OF COLUMBIA ISRAEL INTERNATIONAL AFRICA/MIDDLE EAST INDUSTRY KEYWORD: MEDICAL DEVICES PHARMACEUTICAL MEDICAL BIOTECHNOLOGY SOURCE: Syneron Medical Ltd.

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Syneron Medical Ltd.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Syneron Medical Ltd.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 218,17 0,83%